Abstract: The present disclosure provides a composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels, comprising, as an active ingredient, an ingredient derived from a turmeric.

Abstract: There is provided an active phased array antenna in which power to an Si wafer is separated from power to compound semiconductor chips. An active phased array antenna is an active phased array antenna including a substrate having a plurality of antenna elements; a pseudo wafer containing a group of semiconductor chips including a plurality of semiconductor chips made of compound semiconductors; and a silicon wafer made of silicon, the substrate, the pseudo wafer, and the silicon wafer being stacked on top of each other in this order, and the pseudo wafer includes first feeders for supplying power to the group of semiconductor chips from the substrate; and a second feeder for supplying power to the silicon wafer from the substrate, the second feeder passing through the pseudo wafer in a thickness direction of the pseudo wafer.

Abstract: The present invention provides a composition for improving or maintaining quality of life (QOL), comprising, as an active ingredient, a component derived from turmeric. The present invention relates to a composition for improving or maintaining QOL, comprising, as an active ingredient, at least one of turmeronol A, turmeronol B, and bisacurone. The composition of the present invention for improving or maintaining QOL may comprise 20 ?g or more of turmeronol A and turmeronol B in total per daily intake, may comprise 17 ?g or more of turmeronol A per daily intake, may comprise 5 ?g or more of turmeronol B per daily intake, and may comprise 80 ?g or more of bisacurone per daily intake.

Abstract: A first switch is connected in parallel with a circuit element. A second switch is connected in series with a parallel circuit constituted by the circuit element and the first switch. The first switch and the second switch alternately perform on-off operation.

Abstract: One or more embodiments of the present invention provide a composition for inhibiting TNF-? or IL-6 production, comprising a component derived from turmeric. One or more embodiments of the present invention relate to a composition for inhibiting TNF-? or IL-6 production, comprising at least one of turmeronol A, turmeronol B, and bisacurone. The composition for inhibiting TNF-? or IL-6 production according to one or more embodiments of the present invention may comprise 20 ?g or more of turmeronol A and turmeronol B in total per daily intake, may comprise 17 ?g or more of turmeronol A per daily intake, may comprise 5 ?g or more of turmeronol B per daily intake, and may comprise 80 ?g or more of bisacurone per daily intake.

Abstract: One or more embodiments of the present invention relate to a composition for improving lipid metabolism or carbohydrate metabolism, comprising a component derived from turmeric. One or more embodiments of the present invention relate to a composition for lowering blood glucose level, reducing blood hemoglobin A1c content, or increasing blood HDL-cholesterol content, a composition for treating or preventing metabolic syndrome, or a composition for improving lipid metabolism or carbohydrate metabolism, wherein each composition comprises, as an active ingredient, at least one of turmeronol A, turmeronol B, and bisacurone. Each composition may comprise 20 ?g or more of turmeronol A and turmeronol B in total per daily intake, may comprise 17 ?g or more of turmeronol A per daily intake, may comprise 5 ?g or more of turmeronol B per daily intake, and may comprise 80 ?g or more of bisacurone per daily intake.

Abstract: The present invention provides a composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels, comprising, as an active ingredient, an ingredient derived from a turmeric. The present invention relates to a composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels, comprising, as an active ingredient, at least one of turmeronol A, turmeronol B and bisacurone. The present invention also relates to a composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels, comprising a turmeric as an active ingredient.

Abstract: This invention provides a composition comprising, as an active ingredient, a turmeric-derived ingredient, which is useful for treatment, prevention, or amelioration of Alzheimer's disease. This invention relates to a composition for treatment of Alzheimer's disease, a composition for suppression of brain nerve cell death, a composition for suppression of microglia activation induced by amyloid ? peptide, or a composition for suppression of PGE2, TNF-?, or IL-1? production induced by amyloid ? peptide comprising, as an active ingredient, a turmeric extract extracted with at least one extraction solvent selected from water and a hydrophilic organic solvent or at least one of termeronol A and termeronol B.

Abstract: The present invention provides a composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels, comprising, as an active ingredient, an ingredient derived from a turmeric. The present invention relates to a composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels, comprising, as an active ingredient, at least one of turmeronol A, turmeronol B and bisacurone. The present invention also relates to a composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels, comprising a turmeric as an active ingredient.

Abstract: A first switch is connected in parallel with a circuit element. A second switch is connected in series with a parallel circuit constituted by the circuit element and the first switch. The first switch and the second switch alternately perform on-off operation.

Abstract: There is provided a polyphase filter (5) that generates first differential signals from first signals amplified by a first transistor (2-1), outputs the first differential signals from a first output terminal (5-1) and a third output terminal (5-3), generates second differential signals from second signals amplified by a second transistor (2-2), and outputs the second differential signals from the first output terminal (5-1) and the third output terminal (5-3).

Abstract: It is an object of the present invention to provide a composition having an anti-inflammatory action. The anti-inflammatory composition of the present invention comprises, as an active ingredient, a compound represented by the following Formula 1. In the following Formula 1, R1 represents hydrogen or a hydroxy group, and A represents a phenyl group optionally substituted with a hydroxyl group or a methyl group, or a cyclohexenyl group substituted with a hydroxyl group and a methylene group.

Abstract: The invention provides an improved process for preparing a carbostyril compound (1) or a salt thereof that is useful as a medicament, which makes it possible to prepare it more safely and efficiently. In more detail, the invention provides an improved process for preparing the carbostyril compound (1) by heating the compound (4) with a high boiling solvent in hydrochloric acid under reflux to give the compound (5) safely; and then acylating the compound (5).

Abstract: Producing an immunostimulating composition containing lactic acid bacteria having IL-12 production-inducing activity, by culturing lactic acid bacteria belonging to the genus Lactobacillus, immediately killing the bacteria at the point of time at which the pH of the culture medium substantially stops decreasing, and then adding the obtained killed cells to a food-or-drink product.

Abstract: The invention provides an improved process for preparing a carbostyril compound (1) or a salt thereof that is useful as a medicament, which makes it possible to prepare it more safely and efficiently. In more detail, the invention provides an improved process for preparing the carbostyril compound (1) by heating the compound (4) with a high boiling solvent in hydrochloric acid under reflux to give the compound (5) safely; and then acylating the compound (5).